TheEdgeResearch
Home / Stocks / XBI

State Street SPDR S&P Biotech ETF (XBI)

AMEX Financial Services Asset Management - Global
$140.72 ▲ +0.95%
Market Cap
$8.39B
Sector
Financial Services
Industry
Asset Management - Global
Beta
1.12
52-Wk Range
80.9-143.46
CEO
Country
US
Currency
USD

The State Street SPDR S&P Biotech ETF (XBI) is designed to closely track the total return performance of the S&P Biotechnology Select Industry Index, prior to accounting for fees and expenses. Its primary objective is to offer investors targeted exposure exclusively to the biotechnology segment of the market. A distinguishing characteristic is its underlying modified equal-weighted index, which fosters a diversified portfolio by ensuring balanced representation across large, mid, and small-capitalization biotech companies, thereby minimizing concentration risk. This structure makes XBI a preci…

Open full interactive analysis & DCF →